Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Stroke
In brief
To evaluate whether NESA microcurrents can be used as an effective treatment for various sequelae present in stroke patients, specifically in the treatment of spasticity, balance, pain; and whether it affects quality of life, performance of activities of daily living and quality of sleep.
Key facts
- Study ID
- NCT05853952
- Run by
- University of Las Palmas de Gran Canaria
- People needed
- 30
- Starts
- 2023-04-24
- Expected to finish
- 2026-10-23
- Last updated by the study team
- 2026-05-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- People who have suffered a stroke with an evolution between 6 months and 6 years.
- Optimal cognitive capacity and mentally competent to participate in the study and complete the required questionnaires.
- People able of standing upright, including those who need technical aids.
You may not qualify if…
- Present some of the contraindications for a treatment with NESA XSIGNAL®: pacemakers, internal bleeding, not to apply electrodes on skin in bad condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and/or phobia to electricity.
- Not having signed the informed consent form.
- Presenting any additional injury or pathology during the study.
- Not having the optimal cognitive capacities for understanding and participating in the study.
Where it is running
- Mariola Lledó Amat — Las Palmas de Gran Canaria, Las Palmas, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.